Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

101 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-06-30

Study Completion Date

2018-05-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the proportion of prostate cancer patients receiving external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT) with controlled blood sugars (fasting glucose and hemoglobin A1c), blood pressure, and cholesterol profile (total cholesterol, LDL, HDL, triglycerides) at baseline, 3 months, and 12 months after completing radiation treatment. In addition, receipt of guideline-recommended cardiovascular, primary and preventive care as well as patient-reported quality of life and satisfaction with care among these patients will be evaluated at baseline and 12 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Radiation and Androgen Ablation for Prostate Cancer

NCT01517451

Adenocarcinoma of the Prostate

ACTIVE_NOT_RECRUITING PHASE1/PHASE2

Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate

NCT03034187

Prostate Cancer

RECRUITING

Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

NCT07325721

Prostate Cancer Prostate Cancer Patients Treated by Radiotherapy

RECRUITING PHASE2

Observation or Radical Treatment in Patients With Prostate Cancer

NCT00499174

Prostate Cancer

TERMINATED NA

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

NCT00331773

Prostate Cancer

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non-metastatic prostate cancer patients

Histologically-confirmed, non-metastatic prostate cancer patients who received external beam radiation treatment with androgen deprivation therapy (total ADT duration \> 3 months) for definitive treatment.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically-confirmed, non-metastatic prostate cancer
* Patients who will receive external beam radiation treatment with androgen deprivation therapy (total ADT duration \> 3 months) for curative treatment, either in the definitive or post-prostatectomy setting
* Patients who have a primary care provider
* Informed consent obtained and signed
* Ability to read and write English
* Age \>= 18
* No mental incompetence which would preclude completion of questionnaires

Exclusion Criteria

* Prior cancer, pelvic radiation treatment or chemotherapy
* Patients who do not have a primary care provider
* Prior ADT
* Mental incompetence which would preclude completion of questionnaires
* Unable to read and write English

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No